Plain-English translation of NCT06682390 on ClinicalTrials.gov ↗ · Source last updated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Men with advanced prostate cancer often gain weight and develop heart health problems while on androgen deprivation therapy, a common hormone treatment. This study is testing whether a low-calorie, anti-inflammatory diet combined with regular walking can help reduce weight, improve heart health markers, and boost quality of life. The researchers want to see if the diet and exercise program works the same way for African American men and white men.
Hormone therapy for prostate cancer often causes unwanted weight gain and increases the risk of heart disease, but there is very little research on whether men of different racial backgrounds respond to diet and exercise programs in the same way. This study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
The study lasts 6 months total and is divided into two 3-month phases. In the first 3 months, you will continue eating and exercising as you normally do while researchers collect baseline measurements of your weight, body composition, blood pressure, and blood work. In the second 3 months, you will follow a low-calorie, anti-inflammatory diet (eating about 500 fewer calories per day) and walk for 1 hour on 3 days per week. Researchers will measure the same health markers again at the end of each phase to see how the diet and exercise program affects you.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States